Study: A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer
Phase III
· Site: SITE008 (KOR) (Dr. Kim)
· consented 2023-03-18
Adverse events
6
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Grade 1 Vomiting — outcome: RECOVERED/RESOLVED; onset 2023-05-28 (study day 52); relationship: not assessed
moderate
assessed
2026-08-18
Grade 2 Fatigue — outcome: RECOVERED/RESOLVED; onset 2023-06-21 (study day 76); relationship: N
severe
assessed
2026-08-18
Grade 3 Anaemia — outcome: RECOVERED/RESOLVED; onset 2024-01-10 (study day 279); relationship: not assessed
mild
assessed
2026-08-18
Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2024-05-30 (study day 420); relationship: not assessed
mild
assessed
2026-08-18
Grade 1 Vomiting — outcome: RECOVERED/RESOLVED; onset 2024-07-12 (study day 463); relationship: not assessed
mild
assessed
2026-08-18
Grade 1 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2024-09-11 (study day 524); relationship: N
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.